Χώρα: Καναδάς
Γλώσσα: Αγγλικά
Πηγή: Health Canada
CHLORHEXIDINE GLUCONATE
COLGATE-PALMOLIVE CANADA INC
A01AB03
CHLORHEXIDINE
0.12%
MOUTHWASH
CHLORHEXIDINE GLUCONATE 0.12%
BUCCAL
470ML
Prescription
MISCELLANEOUS ANTI-INFECTIVES
Active ingredient group (AIG) number: 0107629007; AHFS:
CANCELLED POST MARKET
2018-10-10
Page 1 of 19 PRODUCT MONOGRAPH PERIOGARD Chlorhexidine Gluconate 0.12% Oral Rinse, USP Liquid, 0.12% Chlorhexidine Gluconate Antigingivital Oral Rinse Colgate-Palmolive Canada Inc. Date of Revision: Two Morneau Shepell Centre December 3, 2019 5 th Floor, 895 Don Mills Road Toronto, Ontario M3C 1W3 Submission Control No: 232067 Page 2 of 19 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ............................................................................ 3 SUMMARY PRODUCT INFORMATION ............................................................................................. 3 INDICATIONS AND CLINICAL USE ................................................................................................... 3 CONTRAINDICATIONS ....................................................................................................................... 4 WARNINGS AND PRECAUTIONS ..................................................................................................... 4 ADVERSE REACTIONS ....................................................................................................................... 5 DOSAGE AND ADMINISTRATION ..................................................................................................... 6 OVERDOSAGE ..................................................................................................................................... 7 ACTION AND CLINICAL PHARMACOLOGY ..................................................................................... 8 STORAGE AND STABILITY ................................................................................................................ 9 SPECIAL HANDLING INSTRUCTIONS ............................................................................................ 10 DOSAGE FORMS, COMPOSITION AND PACKAGING ................................................................. 10 PART II: SCIENTIFIC INFORMATION .................................................................................................. 11 P Διαβάστε το πλήρες έγγραφο